In this video series, two Fools delve closely into one FTSE blue-chip company. Here, Jill Ralph and Nate Weisshaar put AstraZeneca (LSE: AZN) (NYSE: AZN.US) under the spotlight…
https://youtu.be/iXZiiV7Mjaw
A Closer Look At AstraZeneca plc
VIDEO: Two Fools analyse AstraZeneca plc (LON: AZN).
Posted by
Published After more than 5 years with The Motley Fool's publishing business in the U.S., Jill packed up and moved to London in the Spring of 2011 to join the team as Managing Director. It didn't take her long to start complaining about the weather. When she's not taking advantage of the generous 'free book' program at work, she enjoys studying and writing about companies of all shapes and sizes, with a particular interest in the people running those businesses and refusing to play by the rules. Before joining the Fool, Jill spent 5 years in the publishing industry, working on the news team for a regional newspaper as well as Managing Editor of a niche B-to-B magazine.
More on: AZN
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.
